Antifungal prophylaxis and the rate of bacteremia among neutropenic patients [4]

Clinical Infectious Diseases

Volumn 34, Issue 2, 2002, Pages 289-291

  Viscoli, Claudio ^a   Paesmans, Marianne ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIMICROBIAL THERAPY; BACTEREMIA; BLOOD SAMPLING; DISEASE DURATION; FEBRILE NEUTROPENIA; HUMAN; INFECTION RATE; LETTER; MYCOSIS; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS;

ANTIFUNGAL AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; HUMANS; MYCOSES; NEUTROPENIA;

EID: 0037079919     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/324366     Document Type: Letter

References (8)

1. Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients
2. Anti-fungal antibiotics and breakthrough bacteremias
3. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: Lesson from four EORTC trials
4. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
5. The design, analysis and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient
6. Risk factors for fungal infections in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis
7. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
8. Empiric antifungal therapy in febrile granulocytopenic patients